Comparing chair-based and standard exercise programs for people with COPD
Official title: Comparison of the Effectiveness of Chair-based and Standard Exercise Programs in People With COPD
Run by Istanbul Medipol University Hospital · NCT06201299 · Data updated 2026-11-12
This study is testing whether a chair-based exercise program is just as helpful as a standard exercise program for people with COPD who are starting pulmonary rehabilitation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 64 (estimated) |
| Sponsor | Istanbul Medipol University Hospital Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Status | Recruiting |
| Started | January 20, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT06201299 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 with a clinical diagnosis of COPD and stable health status.
✕Probably not a fit
Patients with severe comorbidities or those who have recently participated in a pulmonary rehabilitation program may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves patients diagnosed with COPD who are referred to pulmonary rehabilitation. Participants will be randomly assigned to either a standard exercise program group or a chair-based exercise program group. Both groups will receive initial training in the hospital and will perform exercises at home using provided videos, with additional online training sessions with a physiotherapist. The program lasts for 8 weeks, with exercises conducted five days a week.
Why it matters
Potential benefit: If successful, this study could improve exercise tolerance and quality of life for patients with COPD.
How similar studies have gone: Previous studies have shown positive outcomes with exercise interventions in COPD, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 18-75 years * Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS). * Presence of dyspnea on exertion * Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks \*Having smart phone usage skills Exclusion Criteria: * Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min). * A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training. * Having participated in a pulmonary rehabilitation program within the last 12 months.
Where it's running
-
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Esra Pehli̇van
- Email: fztesrakambur@yahoo.com
- Phone: 09050585279
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.